Coexisting Calcific Aortic Stenosis and Transthyretin Cardiac Amyloidosis: Real‐World Evaluation of Clinical Characteristics and Outcomes
Patients with AS plus ATTR-CA experience worse clinical outcomes than patients with AS only. Increased awareness of these coexisting conditions may help facilitate earlier screening and improve prognosis.
Authors
- Jenifer Wogen
- Rahul Bhambri
- A. Carmine Colavecchia (ORCID: https://orcid.org/0000-0003-4937-0654)
- Aaron Crowley (ORCID: https://orcid.org/0000-0002-1203-9223)
- Ahmad Masri (ORCID: https://orcid.org/0000-0002-6390-6526)
- Matthew Kent (ORCID: https://orcid.org/0000-0001-8822-8533)
- Darrin Benjumea
- Cindi Pankratova
- Yong Chen (ORCID: https://orcid.org/0009-0006-9094-7012)
- Priti Jhingran
- Jose Maria Jimenez Alvir
Institutions
- Oregon Health & Science University (US)
- Pfizer (United States) (US)
Publication Details
- Journal
- Journal of the American Heart Association
- Published
- 2025-01-16
- DOI
- https://doi.org/10.1161/jaha.123.033251
- Citations
- 10
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 8.06
Funders
- Pfizer